Partnership Brings QuantX Diagnostic AI to More Breast Radiologists
Qlarity Imaging and Blackford have agreed to integrate QuantX within Blackford's curated marketplace. The partnership will combine the implementation and maintenance gains of a platform-based approach with the increased accuracy and improved reader performance benefits of QuantX for breast MRI interpretation to help deliver better outcomes for more radiologists, health systems and patients. This will promote workflow efficiencies and expand distribution of this breast MRI decision support tool, strengthening a shared commitment to improve patient care through innovative technology. The integration will feature the new cloud-based, vendor-neutral format of QuantX, which is currently in development and pending application seeking FDA clearance.
“Breast MRI evaluations are one of the more difficult exams for radiologists. Factoring in the current challenges contributing to widespread radiologist burnout, the question is not if technological advancements are needed, but how they can be developed and implemented to add the most value,” said Qlarity Imaging Chief Executive Officer Jon DeVries. “Partnering with Blackford will help radiologists and their teams overcome current workflow, budget, and productivity challenges, while also providing unique opportunities for innovation with partners to improve the quality of breast cancer screening and diagnosis strategies.”
A key partnership component will be creating efficiencies for radiologists, department administrators, and IT staff, allowing radiologists to focus on patient care. Implementing and managing QuantX using Blackford Platform will reduce deployment time, costs, maintenance, monitoring, and support requirements through a centralized system that can be fully integrated with existing resources to access a wide array of imaging applications. By leveraging Blackford's extensive infrastructure and network, more radiologists will be able to employ the data-driven decision making of QuantX to increase diagnostic accuracy during breast MRI exams.
“We are delighted that Qlarity's QuantX will be available through Blackford's curated marketplace of applications” said Ben Panter, CEO, Blackford Analysis. “We look forward to working with Qlarity to provide our customers and channel partners with simplified access to QuantX through our dedicated platform, to help drive additional clinical value for patients.”